×

img Acces sibility Controls

Research Projects Banner

Research Projects

Targeting endothelin-1 to mitigate the risk of nitrofibrinogen-governed TE induced by cisplatin chemotherapy

Funding Organization
Funding Organization
Department of Biotechnology (DBT)
Quick Information
Area of Research
Life Sciences & Biotechnology
Focus Area
Cisplatin chemotherapy
Start Year
2018
End Year
2021
Sanction Amount
₹ 49.90 L
Status
Completed
Output
No. of Research Paper
00
Technologies (If Any)
00
No. of PhD Produced
N/A
Startup (If Any)
00
No. of Patents
Filed :00
Grant :00
arrowtop